ArticleTranslational oncology2018

Small Molecules Identified from a Quantitative Drug Combinational Screen Resensitize Cisplatin's Response in Drug-Resistant Ovarian Cancer Cells.

Ni Sima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.